Form 4 for PLX Protalix BioTherapeutics, Inc.
Accepted 2022-04-13 00:00:00 ET · period of report 2022-04-11 · accession 0001104659-22-045488 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-13 | 2022-04-11 | PLX | Bashan Dror | Pres, CEO, Dir | P - Purchase | $1.50 | +68.0K | 68.0K | New | +$102.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-11 | P | A | 68,000 | $1.50 | 68,000 | D | — | — | (F1) The reporting person holds the shares in an account with his spouse as joint tenants. |